medipharm labs

STADA and MediPharm Labs Begin First Sales in Germany Under Exclusive Agreement

“This is the beginning of a meaningful long-term partnership dedicated to bringing the unique benefits of GMP-certified medical cannabis to patients in Europe,”

Marijuana Staff

2 Apr 2021 — 1 min read

“This is the beginning of a meaningful long-term partnership dedicated to bringing the unique benefits of GMP-certified medical cannabis to patients in Europe,”

Keith Strachan, President and Interim Chief Executive Officer, MediPharm Labs: “Based on our first deliveries under this portfolio agreement, we are ramping up new products that German patients suffering from chronic pain can count on to meet their individual personalized therapeutic needs.”

The first shipments of dry flower were curated by MediPharm Labs from its network of GMP-certified cultivators.

Manufacturing of extract products is taking place at MediPharm Labs Australia, a GMP-certified and fully licensed production facility.

Original release. www.globenewswire.com/news-release/2021/04/01/2203164/0/en/European-Pharmaceutical-Company-STADA-and-MediPharm-Labs-Begin-First-Sales-in-Germany-Under-Exclusive-Agreement.html

Global Medical Cannabis Documentation Platform Secures Major Investment

The platform, which attracts 350,000 monthly unique visitors, serves as a resource for licensed cultivators and researchers documenting legal cannabis cultivation processes.

The Art of Last-Minute Campaign Promises: Understanding Strategic Timing

The practice of saving significant promises for the final days of a campaign isn't merely coincidental – it's a calculated political strategy that has proven effective across decades of electoral politics.

OCB Rolling Papers Blazes New World Record at Hall of Flowers

The record attempt was part of the larger Hall of Flowers event, which attracted over 13,000 attendees and featured more than 300 vendors.

Medical Cannabis in South Australia: Progress and Pitfalls

These changes represent real progress for patients who can access and afford MC products. They promise to reduce stigma, improve daily life, and potentially expand treatment options.

Read more

Global Medical Cannabis Documentation Platform Secures Major Investment

The Art of Last-Minute Campaign Promises: Understanding Strategic Timing

OCB Rolling Papers Blazes New World Record at Hall of Flowers

Medical Cannabis in South Australia: Progress and Pitfalls